Announcements Trials
Browse Landscape

Phase

Phase NA 31Phase 2 2Phase 4 1

Status

Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 1NIH 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 1Other neoplasm 1Other hematologic neoplasm 1Other 1Lymphoid 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Obesity 1Hematopoietic and Lymphatic System Neoplasm 1

Interventions

pembrolizumab 519Specimen Handling 382Carboplatin 374Magnetic Resonance Spectroscopy 337Cisplatin 328Nivolumab 309Cyclophosphamide 296Radiotherapy 256Paclitaxel 256Gemcitabine 235Biopsy 234Bevacizumab 213Dexamethasone 169durvalumab 166Oxaliplatin 162Rituximab 158Capecitabine 157Fluorouracil 148venetoclax 147Docetaxel 146Etoposide 141atezolizumab 140Drug Therapy 140Doxorubicin 134Ipilimumab 130Prednisone 120Lenalidomide 119Radiosurgery 118Leucovorin 112fludarabine 108

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Resistance Training × 1 year × Clear all
NCT06009926 2026-05-13

Evaluation of Broccoli Seed and Sprout Extract for Detoxification of Carcinogens in Firefighters

National Cancer Institute (NCI)

Phase 2 Active not recruiting
72 enrolled
Other neoplasmOther solid neoplasm

Hematopoietic and Lymphatic System Neoplasm

NCT07228741 2026-04-24

Resistance Exercise and Incretin Mimetic for Cardiometabolic Health in Survivors of ALL With Obesity

St. Jude Children's Research Hospital

Phase 2 Recruiting
20 enrolled
LymphoidOtherOther hematologic neoplasm

Obesity, Precursor Cell Lymphoblastic Leukemia-Lymphoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡